Aidoc, the leading clinical AI platform, today announced strategic partnerships with Cercare Medical and Circle CVI to expand its neurosciences portfolio with advanced MR Perfusion and automated ...

Large, well-powered Phase 1b study, designed to generate clinically and biologically meaningful insights in early Alzheimer’s diseaseClear and ...

Klotho Neurosciences (KLTO) witnessed an astonishing 800% increase in stock value on June 9, 2025, after revealing positive results from pre-clinical studies. The company’s investigations indicated ...

Welcome to the Department of Neurosciences! Together, the Department of Neurosciences at the School of Medicine (SOM), and the Department of Biology in the College of Arts and Sciences (CAS), have ...

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.

Jupiter, Florida, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL ™, a patented ...

Shares of Klotho Neurosciences Inc (NASDAQ:KLTO) skyrocketed over 680% to $1.60 during Monday morning trading after the company highlighted promising pre-clinical study findings for its anti-aging ...

ProMIS Neurosciences ( ($PMN) ) has provided an announcement. On December 12, 2025, ProMIS Neurosciences Inc. announced it has regained compliance ...

Over the course of this year, Klotho Neurosciences has achieved critical strategic and operational milestones: Pipeline Advancement and Regulatory Recognition: The company received Orphan Drug ...

Drexel University College of Medicine is pleased to announce the launch of the Drexel Neurosciences Institute, an innovative collaboration of Drexel's College of Medicine and Global Neurosciences ...

Two poster presentations at ACNP highlight new research on the fundamental biology of molecules targeting synaptic function in CNS disease Insights advance translational model supporting Gate’s lead ...

Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer's disease and ...